Molecular Oncology

SIRT5‐mediated deacetylation of LDHB promotes autophagy and tumorigenesis in colorectal cancer

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma

Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1

Therapeutic cancer prevention: achievements and ongoing challenges – a focus on breast and colorectal cancer

The long noncoding RNA AK002107 negatively modulates miR‐140‐5p and targets TGFBR1 to induce epithelial–mesenchymal transition in hepatocellular carcinoma

Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer

In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53

Identification of lncRNAs associated with early‐stage breast cancer and their prognostic implications

LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL‐6–STAT3 pathway

SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis

High affinity binding of H3K14ac through collaboration of bromodomains 2, 4 and 5 is critical for the molecular and tumor suppressor functions of PBRM1

Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1

SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity

UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis

Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer

Targeting CDK9 for treatment of colorectal cancer

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer

RITA modulates cell migration and invasion by affecting focal adhesion dynamics

Detection of mutational patterns in cell‐free DNA of colorectal cancer by custom amplicon sequencing

Overview of non‐coding mutations in chronic lymphocytic leukemia

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients

Detection of human papillomavirus in cases of head and neck squamous cell carcinoma by RNA‐seq and VirTect

Endothelin‐converting enzyme‐1c promotes stem cell traits and aggressiveness in colorectal cancer cells

Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer

Education aimed at increasing international collaboration and decreasing inequalities

Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition

Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors

Bcl‐2 inhibitors enhance FGFR inhibitor‐induced mitochondrial‐dependent cell death in FGFR2‐mutant endometrial cancer

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation

Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma

ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation

A report from a conference jointly organised by the European Academy of Cancer Sciences and the Pontifical Academy of Sciences, The Vatican, November 16–17, 2018†

Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer

NCS‐1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2

Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation

Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition

The noncoding function of NELFA mRNA promotes the development of oesophageal squamous cell carcinoma by regulating the Rad17‐RFC2‐5 complex

Molecular characterization of an MLL1 fusion and its role in chromosomal instability

Targeting claudin‐overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin